Search Press releases Keywords From To 18 May 2004 UCB S.A. launches a friendly offer to acquire Celltech Group plc, the leading UK-based biotech company Read More 27 Apr 2004 UCB 44212, the second analogue of UCB Pharma’s anti-epileptic, KEPPRA*, enters clinical study phase Read More 25 Mar 2004 UCB Group: confirmed increase of 2% in net results Read More 22 Mar 2004 UCB Group : Keppra® Patent Read More 6 Feb 2004 UCB Pharma announces partnership with Dynavax to develop and market products for the treatment of allergies Read More 6 Feb 2004 UCB - Acquisition of innovative treatments in allergy Read More Pagination First page Previous page Previous … Page 196 Page 197 Page 198 Page 199 Current page 200 Page 201 Page 202 Page 203 Page 204 Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
